p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells

Cell Adhesion and Migration

Volumn 5, Issue 2, 2011, Pages 144-149

  Mak, Alan S ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Actin cytoskeleton; Caldesmon; Cell migration and invasion; p53; Podosomes; PTEN; Stat3; Vascular smooth muscle cells

Indexed keywords

PROTEIN P53;

APOPTOSIS; ATHEROSCLEROSIS; CANCER INHIBITION; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; FIBROBLAST; MIGRATION INHIBITION; PHENOTYPE; PODOSOME; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SMOOTH MUSCLE FIBER; TUMOR GROWTH; VASCULAR SMOOTH MUSCLE;

EID: 79952324025     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.2.14375     Document Type: Review

References (87)

1. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278:261-3. (Pubitemid 9129076)
2. Linzer DI, Levine AJ. Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979; 17:43-52. (Pubitemid 9188209)
3. Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 2007; 6:1006-10. (Pubitemid 46708570)
4. Roger L, Gadea G, Roux P. Control of cell migration: a tumour suppressor function for p53? Biol Cell 2006; 98:141-52.
5. Mukhopadhyay UK, Mak AS. p53: is the guardian of the genome also a suppressor of cell invasion? Cell Cycle 2009; 8:2481.
6. Mukhopadhyay UK, Eves R, Jia L, Mooney P, Mak AS. p53 suppresses Src-induced podosome and rosette formation and cellular invasiveness through the upregulation of caldesmon. Mol Cell Biol 2009; 29:3088-98.
7. Mukhopadhyay UK, Mooney P, Jia L, Eves R, Raptis L, Mak AS. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol 2010; 30:4980-95.
8. Comer KA, Dennis PA, Armstrong L, Catino JJ, Kastan MB, Kumar CC. Human smooth muscle alphaactin gene is a transcriptional target of the p53 tumor suppressor protein. Oncogene 1998; 16:1299-308. (Pubitemid 28138202)
9. Mukhopadhyay D, Tsiokas L, Sukhatme VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55:6161-5.
10. Sun Y, Sun Y, Wenger L, Rutter JL, Brinckerhoff CE, Cheung HS. Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene. Ann N Y Acad Sci 1999; 878:638-41. (Pubitemid 29353635)
11. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19. (Pubitemid 43069320)
12. Okorokov AL, Rubbi CP, Metcalfe S, Milner J. The interaction of p53 with the nuclear matrix is mediated by F-actin and modulated by DNA damage. Oncogene 2002; 21:356-67. (Pubitemid 34123798)
13. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T. p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol 2000; 2:709-17.
14. Nishio K, Inoue A. Senescence-associated alterations of cytoskeleton: extraordinary production of vimentin that anchors cytoplasmic p53 in senescent human fibroblasts. Histochem Cell Biol 2005; 123:263-73. (Pubitemid 40674677)
15. Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 2009; 139:1327-41.
16. Wang SP, Wang WL, Chang YL, Wu CT, Chao YC, Kao SH, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11:694-704.
17. Guo F, Zheng Y. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 2004; 23:5577-85. (Pubitemid 39093035)
18. Gadea G, Roger L, Anguille C, de TM, Gire V, Roux P. TNFalpha induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation. J Cell Sci 2004; 117:6355-64. (Pubitemid 40214562)
19. Gadea G, Lapasset L, Gauthier-Rouviere C, Roux P. Regulation of Cdc42-mediated morphological effects: a novel function for p53. EMBO J 2002; 21:2373-82. (Pubitemid 34546710)
20. Gadea G, De Toledo M, Anguille C, Roux P. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol 2007; 178:23-30. (Pubitemid 47026399)
21. Coutts AS, Weston L, La Thangue NB. A transcription co-factor integrates cell adhesion and motility with the p53 response. Proc Natl Acad Sci USA 2009; 106:19872-7.
22. Zuchero JB, Coutts AS, Quinlan ME, Thangue NB, Mullins RD. p53-cofactor JMY is a multifunctional actin nucleation factor. Nat Cell Biol 2009; 11:451-9.
23. Mercer J, Bennett M. The role of p53 in atherosclerosis. Cell Cycle 2006; 5:1907-9. (Pubitemid 44435291)
24. Guevara NV, Kim HS, Antonova EI, Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. J Clin Invest 1999; 5:335-9. (Pubitemid 29124372)
25. van Vlijmen BJ, Gerritsen G, Franken AL, Boesten LS, Kockx MM, Gijbels MJ, et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res 2001; 88:780-6. (Pubitemid 32429973)
26. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007; 39:86-93.
27. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84:767-801. (Pubitemid 38823766)
28. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007; 17:107-17. (Pubitemid 46341826)
29. Yamaguchi H, Pixley F, Condeelis J. Invadopodia and podosomes in tumor invasion. Eur J Cell Biol 2006; 85:213-8.
30. Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 2008; 20:235-41.
31. Abiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 2009; 122:3037-49.
32. Block MR, Badowski C, Millon-Fremillon A, Bouvard D, Bouin A, Faurobert E, et al. Podosome-type adhesions and focal adhesions, so alike yet so different. Eur J Cell Biol 2008; 87:491-506.
33. Xiao H, Eves R, Yeh C, Kan W, Xu F, Mak A, et al. Phorbol ester-induced podosomes in normal human bronchial epithelial cells. J Cell Physiol 2009; 218:366-75.
34. Xiao H, Bai XH, Kapus A, Lu WY, Mak AS, Liu M. PKC cascade regulates recruitment of MMP-9 to podosomes and its release and activation. Mol Cell Biol 2010; 30:5545-61.
35. Rottiers P, Saltel F, Daubon T, Chaigne-Delalande B, Tridon V, Billottet C, et al. TGFbeta-induced endothelial podosomes mediate basement membrane collagen degradation in arterial vessels. J Cell Sci 2009; 122:4311-8.
36. Hai CM, Hahne P, Harrington EO, Gimona M. Conventional protein kinase C mediates phorboldibutyrate- induced cytoskeletal remodeling in a7r5 smooth muscle cells. Exp Cell Res 2002; 280:64-74. (Pubitemid 35230368)
37. Machesky L, Jurdic P, Hinz B. Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures. Workshop on Invadopodia, Podosomes and Focal Adhesions in Tissue Invasion. EMBO Rep 2008; 9:139-43.
38. Symons M. Cell biology: watching the first steps of podosome formation. Curr Biol 2008; 18:925-7.
39. Weaver AM. Invadopodia: specialized cell Structures for cancer invasion. Clin Exp Metastasis 2006; 23:97-105. (Pubitemid 44440169)
40. Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol 2002; 12:1270-8. (Pubitemid 34869876)
41. Luxenburg C, Geblinger D, Klein E, Anderson K, Hanein D, Geiger B, et al. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS ONE 2007; 2:179.
42. Linder S, Hufner K, Wintergerst U, Aepfelbacher M. Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J Cell Sci 2000; 113:4165-76. (Pubitemid 32000684)
43. Wolfenson H, Henis YI, Geiger B, Bershadsky AD. The heel and toe of the cell's foot: a multifaceted approach for understanding the structure and dynamics of focal adhesions. Cell Motil Cytoskeleton 2009; 66:1017-29.
44. Dovas A, Gevrey JC, Grossi A, Park H, bou-Kheir W, Cox D. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. J Cell Sci 2009; 122:3873-82.
45. Webb BA, Eves R, Crawley SW, Zhou S, Cote GP, Mak AS. PAK1 induces podosome formation in A7r5 vascular smooth muscle cells in a PAK-interacting exchange factor-dependent manner. Am J Physiol Cell Physiol 2005; 289:898-907.
46. Wells A, Huttenlocher A, Lauffenburger DA. Calpain proteases in cell adhesion and motility. Int Rev Cytol 2005; 245:1-16.
47. Kuzuya M, Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 2003; 10:275-82.
48. Courtneidge SA, Azucena EF, Pass I, Seals DF, Tesfay L. The SRC substrate Tks5, podosomes (invadopodia) and cancer cell invasion. Cold Spring Harb Symp Quant Biol 2005; 70:167-71. (Pubitemid 44124868)
49. Sobue K, Muramoto Y, Fujita M, Kakiuchi S. Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci USA 1981; 78:5652-5. (Pubitemid 12245208)
50. Lin JJ, Li Y, Eppinga RD, Wang Q, Jin JP. Chapter 1: roles of caldesmon in cell motility and actin cytoskeleton remodeling. Int Rev Cell Mol Biol 2009; 274:1-68.
51. Eves R, Webb BA, Zhou S, Mak AS. Caldesmon is an integral component of podosomes in smooth muscle cells. J Cell Sci 2006; 119:1691-702. (Pubitemid 43810996)
52. Tanaka J, Watanabe T, Nakamura N, Sobue K. Morphological and biochemical analyses of contractile proteins (actin, myosin, caldesmon and tropomyosin) in normal and transformed cells. J Cell Sci 1993; 104:595-606. (Pubitemid 23098697)
53. Morita T, Mayanagi T, Yoshio T, Sobue K. Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation. J Biol Chem 2007; 282:8454-63. (Pubitemid 47093626)
54. Yamakita Y, Oosawa F, Yamashiro S, Matsumura F. Caldesmon inhibits Arp2/3-mediated actin nucleation. J Biol Chem 2003; 278:17937-44. (Pubitemid 36799400)
55. Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 2009; 102:19-65.
56. Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, et al. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res 2008; 102:1036-45. (Pubitemid 351667857)
57. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 2003; 3:117-30.
58. Chalhoub N, Baker SJ. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009; 4:127-50.
59. Oikawa T, Itoh T, Takenawa T. Sequential signals toward podosome formation in NIH-src cells. J Cell Biol 2008; 182:157-69. (Pubitemid 352008629)
60. Davidson L, Maccario H, Perera NM, Yang X, Spinelli L, Tibarewall P, et al. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene 2010; 29:687-97.
61. Dey N, Crosswell HE, De P, Parsons R, Peng Q, Su D, et al. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 2008; 68:1862-71. (Pubitemid 351416572)
62. Leslie NR, Yang X, Downes CP, Weijer CJ. PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 2007; 17:115-25.
63. Leslie NR, Maccario H, Spinelli L, Davidson L. The significance of PTEN's protein phosphatase activity. Adv Enzyme Regul 2009; 49:190-6.
64. Poon JS, Eves R, Mak AS. Both lipid- and protein-phosphatase activities of PTEN contribute to the p53-PTEN anti-invasion pathway. Cell Cycle 2010; 9:4450-4.
65. Bharti S, Inoue H, Bharti K, Hirsch DS, Nie Z, Yoon HY, et al. Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol 2007; 27:8271-83. (Pubitemid 350234239)
66. Destaing O, Sanjay A, Itzstein C, Home WC, Toomre D, Camilli PD, et al. The Tyrosine Kinase Activity of c-Src Regulates Actin Dynamics and Organization of Podosomes in Osteoclasts. Mol Biol Cell 2008; 19:394-404. (Pubitemid 351186162)
67. Silva CM. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 2004; 23:8017-23. (Pubitemid 39468859)
68. Zhou S, Webb BA, Eves R, Mak AS. Effects of tyrosine phosphorylation of cortactin on podosome formation in A7r5 vascular smooth muscle cells. Am J Physiol Cell Physiol 2006; 290:463-71.
69. Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA. The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell 2009; 20:1302-11.
70. Thompson O, Kleino I, Crimaldi L, Gimona M, Saksela K, Winder SJ. Dystroglycan, Tks5 and Src mediated assembly of podosomes in myoblasts. PLoS ONE 2008; 3:3638.
71. Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010; 189:13-22.
72. Gao SP, Bromberg JF. Touched and moved by STAT3. Sci STKE 2006; 2006:30.
73. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 2006; 172:245-57. (Pubitemid 43112971)
74. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74. (Pubitemid 46962095)
75. McKenna LB, Zhou GL, Field J. Isoform-specific functions of Akt in cell motility. Cell Mol Life Sci 2007; 64:2723-5. (Pubitemid 351152261)
76. Meima ME, Webb BA, Witkowska HE, Barber DL. The sodium-hydrogen exchanger NHE1 is an Akt substrate necessary for actin filament reorganization by growth factors. J Biol Chem 2009; 284:26666-75.
77. Zhou GL, Zhuo Y, King CC, Fryer BH, Bokoch GM, Field J. Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol 2003; 23:8058-69. (Pubitemid 37377498)
78. Higuchi M, Onishi K, Kikuchi C, Gotoh Y. Scaffolding function of PAK in the PDK1-Akt pathway. Nat Cell Biol 2008; 10:1356-64.
79. Bokoch GM. Biology of the p21-Activated Kinases. Annu Rev Biochem 2003; 72:743-81. (Pubitemid 36930459)
80. Zhao ZS, Manser E. PAK and other Rho-associated kinases: effectors with surprisingly diverse mechanisms of regulation. Biochem J 2005; 386:201-14. (Pubitemid 40343777)
81. Song X, Chen X, Yamaguchi H, Mouneimne G, Condeelis JS, Eddy RJ. Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells. J Cell Sci 2006; 119:2871-81. (Pubitemid 44177865)
82. Foster DB, Shen LH, Kelly J, Thibault P, Van Eyk JE, Mak AS. Phosphorylation of Caldesmon by p21-activated Kinase. Implications for the Ca(2+) sensitivity of smooth muscle contraction. J Biol Chem 2000; 275:1959-65.
83. Webb BA, Zhou S, Eves R, Shen L, Jia L, Mak AS. Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys 2006; 456:183-93. (Pubitemid 44880282)
84. Zhao ZS, Manser E, Loo TH, Lim L. Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol 2000; 20:6354-63. (Pubitemid 30650222)
85. Manser E, Loo TH, Koh CG, Zhao ZS, Chen XQ, Tan L, et al. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell 1998; 1:183-92. (Pubitemid 128378659)
86. Mott HR, Nietlispach D, Evetts KA, Owen D. Structural Analysis of the SH3 Domain of beta-PIX and Its Interaction with alpha-p21 Activated Kinase (PAK). Biochemistry 2005; 44:10977-83. (Pubitemid 41209034)
87. Hoefen RJ, Berk BC. The multifunctional GIT family of proteins. J Cell Sci 2006; 119:1469-75. (Pubitemid 43732975)